Identification and cloning of a new gene (2A3-2), homologous to human translational elongation factor, upregulated in a proliferating rat smooth muscle cell line and in carotid hyperplasia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1650-1657

  Zibara, Kazem ^a   Bourdillon, Marie Claude ^a   Chignier, Elza ^a   Covacho, Chantai ^a   McGregor, John L ^a  

^a INSERM   (France)

Author keywords

Cell culture; Differential display; Rat carotid hyperplasia; Smooth muscle cell; Translational elongation factor; Virtual northern

Indexed keywords

ELONGATION FACTOR;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; MALE; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; TRANSLATION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0033003060     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1650     Document Type: Article

References (59)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Schwartz SM, Camphell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
3. Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR. Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells: correlation with cell density and proliferative state. Arteriosclerosis. 1989;9: 633-643.
4. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988;58:249-261.
5. Thyberg J, Blomgren K, Hedin U, Dryjski M. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study. Cell Tissue Res. 1995;281:421-433.
6. Thyberg J, Blomgren K, Roy J, Tran PK, Hedin U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin. J Histochem Cytochem. 1997;45:837-846.
7. Thyberg J, Hedin U, Solund M, Palmberg L, Bottger BA. Regulation of differential properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990;10:966-990.
8. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest. 1985;76:125-131.
9. Rosenfeld ME, Tsukada T, Chait A, Bierman EL, Gown AM, Ross R. Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:24-34.
10. Dartsch PC, Bauriedel G., Schinko I, Weiss HD, Hofling B, Betz E. Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy. Atherosclerosis. 1989;80: 149-157.
11. Fowler SD, Mayer EP, Greenspan P. Foam cells and atherogenesis. Ann N Y Acad Sci. 1985;454:79-90.
12. Campbell GR, Campbell JH. The phenotypes of smooth muscle expressed in human atheroma. Ann N Y Acad Sci. 1990;598:143-158.
13. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones: implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol. 1996;16:815-820.
14. Chamley-Campbell JH, Campbell GR, Ross R. The smooth muscle cell in culture. Plnsiol Rev. 1979;59:1-61.
15. Absher M, Woodcock-Mitchell J, Mitchell J, Baldor L, Low R, Warshaw D. Characterization of vascular smooth muscle cell phenotype in long-term culture. In Vitro Cell Dev Biol. 1989;25:183-192.
16. Perez-Reyes N, Halbert CL, Smith PP, Benditt EP, McDougall JK. Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci U S A. 1992;89:1224-1228.
17. Blaes N, Bourdillon MC, Daniel-Lamaziere JM, Michaille JJ, Andujar M, Covacho C. Isolation of two morphologically distinct cell lines from rat arterial smooth muscle expressing high tumorigenic potentials. In Vitro Cell Dev Biol. 1991;27A:725-734.
18. Shanahan CM. Weissberg PL. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1998;18:333-338.
19. Benditt EP. Evidence for a monoclonal origin of human atherosclerotic plaques and some implications. Circulation. 1974;50:650-652.
20. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A. 1983;80:6386-6389.
21. Markowitz SD. Atherosclerosis, just another cancer? J Clin Invest. 1997: 100:2143-2145. Editorial.
22. McCaffrey TA, Du B, Consigli S, Szabo P, Bray PJ, Hartner L, Weksler BB, Sanborn TA, Bergman G, Bush HL Jr. Genomic instability in the type II TGF-betal receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest. 1997;100:2182-2188.
23. Albert RE, Vanderlaan M, Bums FJ, Nishizumi M. Effect of carcinogens on chicken atherosclerosis. Cancer Res. 1977;37:2232-2235.
24. Majesky MW, Reidy MA, Benditt EP, Juchau MR. Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc Natl Acad Sci U S A. 1985;82:3450-3454.
25. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335-340.
26. Penn A, Hubbard FC, Parkes JL. Transforming potential is detectable in arteriosclerotic plaques of young animals. Arterioscler Thromb. 1991;11: 1053-1058.
27. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
28. Hendrix MG, Dormans PH, Kitslaar P, Bosman F, Bruggeman CA. The presence of cytomegaiovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol. 1989;134: 1151-1157.
29. Liang P, Pardee AB. Differential display of eukaryotic mRNA by means of the polymerase chain reaction. Science. 1992;257:967-971.
30. Hadjiisky P, Bourdillon MC. Enzyme cytochemical expression of aortic smooth muscle cell modulation in primary and secondary cultures. Acta Histochem. 1993;94:151-162.
31. Dusserre E, Bourdillon MC, Ciavatti M, Covacho C, Renaud S. Lipid biosynthesis in cultured arterial smooth muscle cells is related to their phenotype. Lipids. 1993;28:589-592.
32. Dusserre E, Bourdillon MC, Pulcini T, Berthezene F. Decrease in high density lipoprotein binding sites is associated with decrease in intracellular cholesterol efflux in dedifferentiated aortic smooth muscle cells. Biochem Biophys Acta. 1994;1212:235-244.
33. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
34. Kraft R, Tardiff J, Krauter KS, Leinwand LA. Using miniprep plasmid DNA for sequencing double stranded templates with sequenase. Biotechniques. 1988;6:544-546.
35. Sanger F, Nicklen S, Coulscen AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74:5463-5467.
36. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403-410.
37. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A. 1988;85:2444-2448.
38. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
39. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
40. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. Touchdown PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 1991;19:4008.
41. Wahle E, Keller W. The biochemistry of 3′-end cleavage and polyadenylation of messenger RNA precursors. Annu Rev Biochem. 1992;61: 419-440.
42. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986;44: 283-292.
43. Proudfoot NJ, Brownlee GG. 3′ Non-coding region sequences in eukaryotic messenger RNA. Nature. 1976;263:211-214.
44. Xin H, Woriax V, Burkhart W, Spremulli. L. Cloning and expression of mitochondrial translational elongation factor Ts from bovine and human liver. J Biol Chem. 1995;270:17243-17249.
45. Shi Y, Fard A, Galeo A, Hutchinson H, Vermani P, Dodge G, Hall D, Shaheen F, Zalewski A. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation. 1994;90:944-951.
46. Simons M, Edelman E, DeKeyser JL, Langer Rosenberg R. Antisense c-myb oligonucleotides inhibit intimai arterial smooth muscle cell accumulation in vivo. Nature. 1992;359:67-70.
47. Mills CJ, Northrup JL, Hullinger TG, Simmons CA, Shebuski RJ, Jones DA. Temporal expression of c-fos mRNA following balloon injury in the rat common carotid artery. Cardiovasc Res. 1996;32:954-961.
48. Autieri MV, Yue TL, Ferstein GZ, Ohlstein E. Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Biochem Biophys Res Commun. 1996;213:827-836.
49. Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1995;1:541-545.
50. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb. 1993;13:120-125.
51. Hu Y, Cheng L, Hochleitner BW, Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol. 1997;17: 2808-2816.
52. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest. 1994;93:339-346.
53. Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Oghiara T, Dzau VJ. Intimai hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 1994;93:1458-1464.
54. Delmolino LM, Castellot JJ. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells. J Cell Physiol. 1997; 173:371-379.
55. Bendeck MP, Regenass S, Tom WD, Giachelli CM, Schwanz SM, Hart C, Reidy MA. Differential expression of alpha 1 type VIII collagen in injured platelet-derived growth factor-BB-stimulated rat carotid arteries. Circ Res. 1996;79:524-531.
56. Koike H, Karas RH, Baur WE, ODonnell TF, Mendelson ME. Differential-display polymerase chain reaction identifies nucleophosmin as an estrogen-regulated gene in human vascular smooth muscle cells. J Vasc Surg. 1996;23:477-482.
57. Wang X, Yue TL, Ohlstein EH, Sung CP, Feuerstein GZ. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem. 1996;271: 24286-24293.
58. Autieri MV, Prystowsky MB, Ohlstein EH. Isolation and characterization of BART-1: a novel balloon angioplasty responsive transcript in rat carotid arteries. DNA Cell Biol. 1996;15:297-304.
59. Nishio Y, Aiello LP, King GL. Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display. FASEB J. 1994;8:103-106.